Microbiological and chemical modification of N-benzoyl-N,2,3,3-tetramethyl-exo-2-norbornanamine (N-benzoylmecamylamine).
D000438:Alcohols / Q000096:biosynthesis / Q000138:chemical synthesis; D000577:Amides / Q000096:biosynthesis / Q000138:chemical synthesis / Q000378:metabolism; D000818:Animals; D000959:Antihypertensive Agents / Q000138:chemical synthesis; D001565:Benzoates / Q000096:biosynthesis / Q000138:chemical synthesis / Q000378:metabolism; D001593:Benzyl Compounds / Q000138:chemical synthesis; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D004987:Ethers / Q000138:chemical synthesis; D005730:Ganglionic Blockers / Q000138:chemical synthesis*; D007659:Ketones / Q000138:chemical synthesis; D008744:Methylamines / Q000138:chemical synthesis; D003904:Mitosporic Fungi / Q000378:metabolism*; D009636:Norbornanes / Q000096:biosynthesis / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology; D051381:Rats; D013329:Structure-Activity Relationship; D013729:Terpenes / Q000378:metabolism*; D014105:Tosyl Compounds / Q000138:chemical synthesis
D000438:Alcohols; D000577:Amides; D000959:Antihypertensive Agents; D001565:Benzoates; D001593:Benzyl Compounds; D004987:Ethers; D005730:Ganglionic Blockers; D007659:Ketones; D008744:Methylamines; D009636:Norbornanes; D013729:Terpenes; D014105:Tosyl Compounds